跳至主要内容
临床试验/NL-OMON52313
NL-OMON52313招募中不适用

Endobiliary radiofrequency ablation for malignant biliary obstruction due to perihilar cholangiocarcinoma: a randomized controlled trial - RACCOO

Amsterdam UMC0 个研究点目标入组 73 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
73

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - 18 years or older.
  • - Capable of providing written and oral informed consent.
  • - Histological or cytological proof of perihilar cholangiocarcinoma
  • (adenocarcinoma).
  • - Perihilar biliary obstruction with indication for drainage with uSEMS.*
  • - Advanced (no candidate for surgical resection) due to metastases, vascular or
  • lymph node (N2). involvement on imaging or during staging laparoscopy according
  • to multidisciplinary team (MDT).
  • *Only patients with pCCA are eligible however in case of reasonable doubt
  • between intrahepatic CCA with a perihilar biliary obstruction or massforming
  • pCCA, patients can be included.

排除标准

  • - Patients who potentially qualify for curative resection of pCCA.
  • - pCCA eligible for liver transplantation.
  • - Life-expectancy less than 3 months.
  • - ERCP and PTC technically not feasible.
  • - Uncontrolled coagulopathy (PTT >1,5x prolonged or thrombocytes below
  • 40*10E9/L).
  • - Ongoing cholangitis or liver abscess. Patients are required to be off
  • antibiotic treatment for cholangitis and/or liver abscess at least 7 days.
  • - Any condition that is unstable or that could jeopardize the safety of the
  • subject and their compliance in the study.
  • - Patients who are pregnant or breastfeeding.

研究者

发起方
Amsterdam UMC

相似试验

Endobiliary radiofrequency ablation for malignant... | 临床试验